Deep EM with Hierarchical Latent Label Modelling for Multi-Site Prostate Lesion Segmentation
Organizations: UCL Hawkes Institute; Department of Medical Physics and Biomedical Engineering, University College London, Gower St, London WC1E 6BT, U.K. · Centre for Medical Imaging, Division of Medicine, University College London, Gower St, London WC1E 6BT, U.K. · Division of Surgery and Interventional Science, University College London, 10 Pond St, London NW3 2PS, U.K. · Cancer Institute, Urology Department, UCLH, University College London, 16-18 Westmoreland St, London W1G 8PH, U.K. ·
Abstract
Label variability is a major challenge for prostate lesion segmentation. In multi-site datasets, annotations often reflect centre-specific contouring protocols, causing segmentation networks to overfit to local styles and generalise poorly to unseen sites in inference. We treat each observed annotation as a noisy observation of an underlying latent 'clean' lesion mask, and propose a hierarchical expectation-maximisation (HierEM) framework that alternates between: (1) inferring a voxel-wise posterior distribution over the latent mask, and (2) training a CNN using this posterior as a soft target and estimate site-specific sensitivity and specificity under a hierarchical prior. This hierarchical prior decomposes label-quality into a global mean with site- and case-level deviations, reducing site-specific bias by penalising the likelihood term contributed only by site deviations. Experiments on three cohorts demonstrate that the proposed hierarchical EM framework enhances cross-site generalisation compared to state-of-the-art methods. For pooled-dataset evaluation, the per-site mean DSC ranges from 29.50% to 39.69%; for leave-one-site-out generalisation, it ranges from 27.91% to 32.67%, yielding statistically significant improvements over comparison methods (p<0.039). The method also produces interpretable per-site latent label-quality estimates (sensitivity alpha ranges from 31.5% to 47.3% at specificity beta approximates 0.99), supporting post-hoc analyses of cross-site annotation variability. These results indicate that explicitly modelling site-dependent annotation can improve cross-site generalisation.
Figures & tables
| Methods | Site 1 | Site 2 | Site 3 | |||
| Dice(%) | HD95(mm) | Dice(%) | HD95(mm) | Dice(%) | HD95(mm) | |
| Split A: Pooled patient-level held-out split | ||||||
| UNet | 38.63±10.41 | 17.04±2.96 | 27.47±9.62^* | 21.25±4.50 | 33.49±6.98^* | 22.06±3.92 |
| Bootstrap | 38.49±9.94 | 16.97±3.14 | 26.69±10.59^* | 22.29±5.12^* | 33.14±7.05^* | 21.41 ± 5.84 |
| Site-EM | 36.46±11.72^* | 18.41±7.07^* | 23.74±9.73^* | 22.99±5.52^* | 34.62±6.15 | 21.86± 4.91 |
| HierEM | 39.69 ± 11.88 | 16.92 ± 3.29 | 29.50 ± 9.13 | 20.46 ± 5.58 | 35.60 ± 7.85 | 21.66±4.11 |
Medical Image Segmentation
Medical image segmentation delineates organs, lesions, and other structures in scans to support measurement, diagnosis, treatment planning, and research.
See all 788 papers